Search Within

Sahar Jalali Farahani

Formats
  1. Meeting Abstract (6)
  2. Journal Article (2)
  3. Review (1)
Groups
  1. GME, Pathology (9)
  2. Graduate Medical Education (9)
  3. Department of Pathology and Laboratory Medicine (8)
  4. GDMT, Pathology and Laboratory Medicine (6)
  5. Gynecology Disease Management Team (6)
  6. Sloan Kettering Institute Postdocs (6)

More Groups

People
  1. Britta Weigelt (6)
  2. Dara Ross (6)
  3. Edi Brogi (6)
  4. Fresia Pareja Zea (6)
  5. Hannah Wen (6)
  6. Jose Dopeso Gonzalez (6)

More People

Years
  1. 2025 (1)
  2. 2024 (6)
  3. 2023 (2)
Publications
  1. Laboratory Investigation (6)
  2. Cytopathology (1)
  3. Modern Pathology (1)
  4. npj Precision Oncology (1)
Publishers
  1. Nature Publishing Group (6)
  2. Nature Research (1)
  3. Springer Nature (1)
  4. Wiley Blackwell (1)

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Performance of the monoclonal antibody B72.3 in diagnosis of malignant carcinomatous serous effusions—A systematic review and meta-analysis of diagnostic performance
    Review

    Lin, A. H.; Hsu, M.; Ng, J. K. M.; Farahani, S. J.; Li, J. J. X.; Nano, J.; Raeisi-Dehkordi, H.; Tang, W.; Vielh, P.; Muka, T.
    Cytopathology (2025)

    Fulltext@MSK | Save
  • RHOA genetic alterations and invasive lobular breast cancer
    Meeting Abstract

    Jalali Farahani, S.; Repetto, M.; Dopeso, H.; Gazzo, A.; Wen, H.; Brogi, E.; Ross, D.; Zhang, H.; Weigelt, B.; Pareja, F.
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • Telomerase-independent genetic drivers of telomere lengthening in breast cancer
    Meeting Abstract

    Jalali Farahani, S.; Blanco-Heredia, J.; Brown, D.; Gazzo, A.; Selenica, P.; Dopeso, H.; da Silva, E. M.; Repetto, M.; Ross, D.; Mandelker, D.; more...
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • Breast cancers harboring genetic alterations in the Wnt/beta-catenin signaling pathway
    Meeting Abstract

    Jalali Farahani, S.; Repetto, M.; Gazzo, A.; Dopeso, H.; Selenica, P.; da Silva, E. M.; Ross, D.; Brown, D.; Wen, H.; Zhang, H.; more...
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • SWI/SNF genetic alterations and immune features in breast cancer
    Meeting Abstract

    Gaede, I.; Schwartz, C.; Jalali Farahani, S.; da Silva, E. M.; Selenica, P.; Ross, D.; Brogi, E.; Wen, H.; Weigelt, B.; Pareja, F.; more...
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • Genomic and epigenomic basis of breast invasive lobular carcinomas lacking CDH1 genetic alterations
    Journal Article

    Dopeso, H.; Gazzo, A. M.; Derakhshan, F.; Brown, D. N.; Selenica, P.; Jalali, S.; Da Cruz Paula, A.; Marra, A.; da Silva, E. M.; Basili, T.; more...
    npj Precision Oncology (2024)

    Fulltext@MSK | Save
  • Nonlobular invasive breast carcinomas with biallelic pathogenic CDH1 somatic alterations: A histologic, immunophenotypic, and genomic characterization
    Journal Article

    Derakhshan, F.; Da Cruz Paula, A.; Selenica, P.; da Silva, E. M.; Grabenstetter, A.; Jalali, S.; Gazzo, A. M.; Dopeso, H.; Marra, A.; Brown, D. N.; more...
    Modern Pathology (2024)

    Fulltext@MSK | Save
  • Establishing early breast cancer diagnosis in Nigeria: A pathology perspective
    Meeting Abstract

    Omoyiola, O.; Betiku, O.; Haruna, M.; Daramola, A.; Abdulkareem, F.; Farahani, S.; Omisore, A.; Omidiji, O.; Sutton, E.; Edelweiss, M.
    Laboratory Investigation (2023)

    Fulltext@MSK | Save
  • Assessment of estrogen receptor, progesterone receptor and HER2 in breast cancers in Nigeria: A comparison between pre and post neoadjuvant chemotherapy results
    Meeting Abstract

    Betiku, O.; Omoyiola, O.; Odujoko, O.; Ntiamoah, P.; Farahani, S.; Alatise, O.; Kingham, P.; Wuraola, F.; Olasehinde, O.; Edelweiss, M.
    Laboratory Investigation (2023)

    Fulltext@MSK | Save